Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Registration - Consultant

Mylan Pharmaceuticals ULC / TIM GILBERT, Consultant

Registration Information

Client name: Mylan Pharmaceuticals ULC
Previous client names
Lobbyist name: TIM GILBERT, Consultant
Initial registration start date: 2004-04-21
Registration status: Inactive
Registration Number: 776377-2230

Associated Communications

Total Number of Communication Reports: 1

Monthly communication reports in the last 6 months: 0

Version 8 of 8 (2010-01-11 to 2010-09-02)

Version 8 of 8 (2010-01-11 to 2010-09-02)



Responsible Officer Name

This is the responsible officer name as provided in the most recent registration for the corporation or organization.

Name Change History:

Mylan Pharmaceuticals ULC

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name From To
Mylan Pharmaceuticals ULC 2010-01-11 2010-09-02

The following names have been used before July 2, 2008

  • Genpharm, Inc.
  • GENPHARM INC.

Responsible Officer Change History

Mylan Pharmaceuticals ULC

Responsible Officer History
Responsible Officer Name From (YYYY-MM-DD) To (YYYY-MM-DD)

All Monthly Communication Reports for Mylan Pharmaceuticals ULC

TIM GILBERT, Gilbert's LLP (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-1 of 1

  • Mylan Pharmaceuticals ULC
    Consultant: TIM GILBERT
    Designated Public Office Holders who participated in the communication:
    • Meena Ballantyne, Assistant Deputy Minister to the Health Products and Food Branch | Health Canada (HC)
    • Muna Idris, Policy Advisor | Health Canada (HC)
    • Elwyn Griffith, Director General Biologics Therapies Directorate | Health Canada (HC)
    • Kwasi Nyarko, Biologics and Genetic Therapies Directorate | Health Canada (HC)
    • Colette Downie, Director General, Marketplace Frameworks Policy Branch | Industry Canada
    • Leah Clark, Director General, Life Sciences Industry Branch | Industry Canada
    • Robert Main, Director, Life Sciences Directorate | Industry Canada
    • Sara Amini, Senior Policy Analyst, Patent and Trademarks Policy Directorate | Industry Canada
    • Mona Frendo, Director, Marketplace Framework Policy Branch | Industry Canada

    Subject Matter of the communication: Health, Industry, Intellectual Property
    Communication date: 2010-01-12
    Posted date: 2010-02-09
    Communication number: 2230-138034 View associated registration

Public offices held: TIM GILBERT


Date Modified: